Aims: To investigate the influence of macular drusen phenotypes on dark adaptation (DA) in intermediate age-related macular degeneration (iAMD). Methods: This cross-sectional, multicentric study enrolled 57 eyes of 43 iAMD patients. Drusen were subclassified as cuticular, soft, reticular pseudodrusen (RPD), or combined soft + RPD based on multimodal imaging. Dark adaptometry (AdaptDx; 20-minute test-time) assessed DA function through rod intercept time (RIT), last measured log sensitivity (LMLS; primary outcome) and area under the DA curve (AUDAC; secondary outcome). OCT volumes (30°x20° field) were analyzed using an AI-enhanced algorithm providing a quantification of chorioretinal layers and pigment epithelium detachments (PED) volumes. Multivariable tobit and linear regression analyzed associations between drusen phenotypes and DA outcomes. Results: Drusen phenotype distribution was: cuticular 13 eyes (22.8%), soft 13 eyes (22.8%), isolated RPD 21 eyes (36.8%), and combined soft + RPD 10 eyes (17.5%). Nearly all eyes reaching RIT within the 20-minute test ceiling (10 of 11 eyes) had cuticular drusen, which showed preserved rod function (LMLS: 2.9 ± 0.2 log-units; AUDAC: 10.3 ± 3.2 log-units·min; RIT: 14.9 ± 4.5 min) despite presenting the highest PED volumes (301 ± 152 nL). Conversely, isolated RPD demonstrated most severe dysfunction (LMLS: 1.7 ± 0.3; AUDAC: 23.7 ± 5.39). Soft drusen showed intermediate impairment (LMLS: 2.2 ± 0.2; AUDAC: 18.4 ± 2.4). Drusen phenotype was the most significant predictor of DA outcomes in both regression models (p < 0.001). Conclusion: Dark adaptometry reveals distinct patterns of DA impairment across drusen phenotypes, necessitating precise drusen classification when dark adaptometry serves as a functional endpoint in iAMD clinical trials. Future studies should employ extended test protocols (40-minute ceiling) to confirm these findings. Clinical trial number: Not applicable.
Drusen-specific dark adaptation profiles in intermediate age-related macular degeneration / P. Forte, L. Ferro Desideri, M. Nassisi, F. Milanesi, A. Feo, I. Bagnasco, S.M. Iglesia, G. Forte, D. Scandella, F. Roccatagliata, V. Fontana, C.M. Eandi, M. Iester, J.K. Jolly, M.S. Zinkernagel, F. Viola, M. Nicolò. - In: INTERNATIONAL JOURNAL OF RETINA AND VITREOUS. - ISSN 2056-9920. - 12:1(2026 Feb 07), pp. 34.1-34.14. [10.1186/s40942-025-00783-1]
Drusen-specific dark adaptation profiles in intermediate age-related macular degeneration
M. Nassisi;F. Viola;
2026
Abstract
Aims: To investigate the influence of macular drusen phenotypes on dark adaptation (DA) in intermediate age-related macular degeneration (iAMD). Methods: This cross-sectional, multicentric study enrolled 57 eyes of 43 iAMD patients. Drusen were subclassified as cuticular, soft, reticular pseudodrusen (RPD), or combined soft + RPD based on multimodal imaging. Dark adaptometry (AdaptDx; 20-minute test-time) assessed DA function through rod intercept time (RIT), last measured log sensitivity (LMLS; primary outcome) and area under the DA curve (AUDAC; secondary outcome). OCT volumes (30°x20° field) were analyzed using an AI-enhanced algorithm providing a quantification of chorioretinal layers and pigment epithelium detachments (PED) volumes. Multivariable tobit and linear regression analyzed associations between drusen phenotypes and DA outcomes. Results: Drusen phenotype distribution was: cuticular 13 eyes (22.8%), soft 13 eyes (22.8%), isolated RPD 21 eyes (36.8%), and combined soft + RPD 10 eyes (17.5%). Nearly all eyes reaching RIT within the 20-minute test ceiling (10 of 11 eyes) had cuticular drusen, which showed preserved rod function (LMLS: 2.9 ± 0.2 log-units; AUDAC: 10.3 ± 3.2 log-units·min; RIT: 14.9 ± 4.5 min) despite presenting the highest PED volumes (301 ± 152 nL). Conversely, isolated RPD demonstrated most severe dysfunction (LMLS: 1.7 ± 0.3; AUDAC: 23.7 ± 5.39). Soft drusen showed intermediate impairment (LMLS: 2.2 ± 0.2; AUDAC: 18.4 ± 2.4). Drusen phenotype was the most significant predictor of DA outcomes in both regression models (p < 0.001). Conclusion: Dark adaptometry reveals distinct patterns of DA impairment across drusen phenotypes, necessitating precise drusen classification when dark adaptometry serves as a functional endpoint in iAMD clinical trials. Future studies should employ extended test protocols (40-minute ceiling) to confirm these findings. Clinical trial number: Not applicable.| File | Dimensione | Formato | |
|---|---|---|---|
|
s40942-025-00783-1 (1).pdf
accesso aperto
Tipologia:
Publisher's version/PDF
Licenza:
Creative commons
Dimensione
1.95 MB
Formato
Adobe PDF
|
1.95 MB | Adobe PDF | Visualizza/Apri |
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.




